National Health Investors Inc NHI.N, NHI is expected to show a rise in quarterly revenue when it reports results on August 6 for the period ending June 30 2025
The Murfreesboro Tennessee-based company is expected to report a 2.3% increase in revenue to $86.929 million from $84.97 million a year ago, according to the mean estimate from 5 analysts, based on LSEG data.
LSEG's mean analyst estimate for National Health Investors Inc is for earnings of 75 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for National Health Investors Inc is $80.00, about 10.8% above its last closing price of $71.33
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Mar. 31 2025 | 1.13 | 1.13 | 1.15 | Beat | 1.6 |
Dec. 31 2025 | 1.11 | 1.11 | 1.12 | Beat | 0.6 |
Sep. 30 2024 | 1.03 | 1.08 | 1.03 | Missed | -4.5 |
Jun. 30 2024 | 1.10 | 1.10 | 1.18 | Beat | 7.4 |
Mar. 31 2024 | 1.05 | 1.06 | 1.12 | Beat | 5.7 |
Dec. 31 2023 | 1.07 | 1.07 | 1.09 | Beat | 1.7 |
Sep. 30 2023 | 1.08 | 1.08 | 1.08 | Met | 0 |
Jun. 30 2023 | 1.08 | 1.08 | 1.06 | Missed | -2.3 |
This summary was machine generated August 4 at 20:19 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)